Access

Insight

Nature 452, 564-570 (3 April 2008) | doi:10.1038/nature06915; Published online 2 April 2008

Open Innovation Challenges

naturejobs

Review Article Enabling personalized cancer medicine through analysis of gene-expression patterns

Laura J. van 't Veer1,2,3 & René Bernards1,3,4,5

Top

Therapies for patients with cancer have changed gradually over the past decade, moving away from the administration of broadly acting cytotoxic drugs towards the use of more-specific therapies that are targeted to each tumour. To facilitate this shift, tests need to be developed to identify those individuals who require therapy and those who are most likely to benefit from certain therapies. In particular, tests that predict the clinical outcome for patients on the basis of the genes expressed by their tumours are likely to increasingly affect patient management, heralding a new era of personalized medicine.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Cancer The molecular outlook

Nature News and Views (31 Jan 2002)

Predicting the future of breast cancer

Nature Medicine News and Views (01 Jan 2003)

See all 5 matches for News And Views